Suchergebnisse - "Merz, Valeria"

PubPharm (6)

1

Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma

enthalten in: Cancer research | 2024

von Pietrobono, S. | Sabbadini, F. | Bertolini, M. | +12

2

The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma

enthalten in: Cancer medicine | 2023

von Procaccio, L. | Merz, V. | Fasano, M. | +21

3

Third-line chemotherapy in advanced biliary cancers (ABC) : pattern of care, treatment outcome and prognostic factors from a multicenter study

enthalten in: Expert review of gastroenterology & hepatology | 2022

von Salati, M. | Rizzo, A. | Merz, V. | +15

4

Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Merz, V. | Zecchetto, C. | Santoro, R. | +11

5

Population pharmacokinetics and exposure-overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Gueorguieva, I. | Tabernero, J. | Melisi, D. | +7

6

Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

enthalten in: JAMA surgery | 2019

von Maggino, L. | Malleo, G. | Marchegiani, G. | +21

CommentIn: JAMA Surg. 2019 Oct 1;154(10):942. - PMID 31339517

1
[1]